nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiludronate—PTPN1—Integrin alphaIIb beta3 signaling—RAPGEF3—chronic obstructive pulmonary disease	0.0525	0.169	CbGpPWpGaD
Tiludronate—PTPN1—respiratory system—chronic obstructive pulmonary disease	0.0495	0.172	CbGeAlD
Tiludronate—PTPN1—connective tissue—chronic obstructive pulmonary disease	0.0435	0.151	CbGeAlD
Tiludronate—PTPN1—Platelet Aggregation (Plug Formation)—RAPGEF3—chronic obstructive pulmonary disease	0.0408	0.131	CbGpPWpGaD
Tiludronate—PTPN1—bronchus—chronic obstructive pulmonary disease	0.0407	0.141	CbGeAlD
Tiludronate—PTPN1—trachea—chronic obstructive pulmonary disease	0.0365	0.127	CbGeAlD
Tiludronate—ATP6V1A—respiratory system—chronic obstructive pulmonary disease	0.0296	0.103	CbGeAlD
Tiludronate—PTPN1—lung—chronic obstructive pulmonary disease	0.0263	0.0911	CbGeAlD
Tiludronate—ATP6V1A—bronchus—chronic obstructive pulmonary disease	0.0244	0.0846	CbGeAlD
Tiludronate—ATP6V1A—trachea—chronic obstructive pulmonary disease	0.0219	0.076	CbGeAlD
Tiludronate—Influenza-like symptoms—Tiotropium—chronic obstructive pulmonary disease	0.0182	0.0454	CcSEcCtD
Tiludronate—ATP6V1A—lung—chronic obstructive pulmonary disease	0.0157	0.0546	CbGeAlD
Tiludronate—Bone pain—Tiotropium—chronic obstructive pulmonary disease	0.0136	0.0338	CcSEcCtD
Tiludronate—ATP6V1A—Iron uptake and transport—HMOX1—chronic obstructive pulmonary disease	0.0131	0.0423	CbGpPWpGaD
Tiludronate—Influenza like illness—Tiotropium—chronic obstructive pulmonary disease	0.0126	0.0315	CcSEcCtD
Tiludronate—ATP6V1A—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS2—chronic obstructive pulmonary disease	0.0113	0.0365	CbGpPWpGaD
Tiludronate—Rhinitis—Roflumilast—chronic obstructive pulmonary disease	0.0104	0.0259	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.00977	0.0314	CbGpPWpGaD
Tiludronate—ATP6V1A—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS3—chronic obstructive pulmonary disease	0.00911	0.0293	CbGpPWpGaD
Tiludronate—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00874	0.0218	CcSEcCtD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—LEP—chronic obstructive pulmonary disease	0.00865	0.0279	CbGpPWpGaD
Tiludronate—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00812	0.0202	CcSEcCtD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00807	0.026	CbGpPWpGaD
Tiludronate—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.0077	0.0192	CcSEcCtD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00719	0.0232	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—KL—chronic obstructive pulmonary disease	0.00679	0.0219	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00672	0.0168	CcSEcCtD
Tiludronate—Rhinitis—Tiotropium—chronic obstructive pulmonary disease	0.00655	0.0163	CcSEcCtD
Tiludronate—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00649	0.0162	CcSEcCtD
Tiludronate—PTPN1—Leptin signaling pathway—LEP—chronic obstructive pulmonary disease	0.00646	0.0208	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00603	0.015	CcSEcCtD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.00593	0.0191	CbGpPWpGaD
Tiludronate—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00583	0.0145	CcSEcCtD
Tiludronate—PTPN1—Signaling events mediated by TCPTP—VEGFA—chronic obstructive pulmonary disease	0.00576	0.0185	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.00576	0.0185	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.00561	0.0181	CbGpPWpGaD
Tiludronate—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.0055	0.0137	CcSEcCtD
Tiludronate—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00529	0.0132	CcSEcCtD
Tiludronate—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.00528	0.0132	CcSEcCtD
Tiludronate—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.00528	0.0132	CcSEcCtD
Tiludronate—PTPN1—Signaling events mediated by TCPTP—EGFR—chronic obstructive pulmonary disease	0.00519	0.0167	CbGpPWpGaD
Tiludronate—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.00518	0.0129	CcSEcCtD
Tiludronate—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00505	0.0126	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.00503	0.0162	CbGpPWpGaD
Tiludronate—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.00499	0.0124	CcSEcCtD
Tiludronate—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00488	0.0122	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.00486	0.0157	CbGpPWpGaD
Tiludronate—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00484	0.0121	CcSEcCtD
Tiludronate—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00484	0.0121	CcSEcCtD
Tiludronate—PTPN1—Leptin signaling pathway—NOS3—chronic obstructive pulmonary disease	0.00484	0.0156	CbGpPWpGaD
Tiludronate—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00462	0.0115	CcSEcCtD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—chronic obstructive pulmonary disease	0.00448	0.0144	CbGpPWpGaD
Tiludronate—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00444	0.0111	CcSEcCtD
Tiludronate—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00444	0.0111	CcSEcCtD
Tiludronate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00438	0.0109	CcSEcCtD
Tiludronate—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00433	0.0108	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00423	0.0105	CcSEcCtD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—EGFR—chronic obstructive pulmonary disease	0.0042	0.0135	CbGpPWpGaD
Tiludronate—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00419	0.0104	CcSEcCtD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	0.00413	0.0133	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—IL1B—chronic obstructive pulmonary disease	0.00412	0.0132	CbGpPWpGaD
Tiludronate—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00408	0.0102	CcSEcCtD
Tiludronate—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00402	0.01	CcSEcCtD
Tiludronate—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00391	0.00974	CcSEcCtD
Tiludronate—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00391	0.00974	CcSEcCtD
Tiludronate—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00391	0.00974	CcSEcCtD
Tiludronate—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00391	0.00974	CcSEcCtD
Tiludronate—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00389	0.0097	CcSEcCtD
Tiludronate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00389	0.00969	CcSEcCtD
Tiludronate—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00383	0.00954	CcSEcCtD
Tiludronate—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00383	0.00954	CcSEcCtD
Tiludronate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00379	0.00946	CcSEcCtD
Tiludronate—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00369	0.00919	CcSEcCtD
Tiludronate—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00369	0.00919	CcSEcCtD
Tiludronate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00367	0.00914	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00341	0.0085	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00341	0.0085	CcSEcCtD
Tiludronate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00337	0.00839	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00334	0.00833	CcSEcCtD
Tiludronate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.0033	0.00821	CcSEcCtD
Tiludronate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.0033	0.00821	CcSEcCtD
Tiludronate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00325	0.00811	CcSEcCtD
Tiludronate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00323	0.00805	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00322	0.00803	CcSEcCtD
Tiludronate—Pain—Formoterol—chronic obstructive pulmonary disease	0.0032	0.00798	CcSEcCtD
Tiludronate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.0032	0.00798	CcSEcCtD
Tiludronate—Pain—Montelukast—chronic obstructive pulmonary disease	0.00314	0.00782	CcSEcCtD
Tiludronate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00311	0.00776	CcSEcCtD
Tiludronate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00308	0.00768	CcSEcCtD
Tiludronate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00307	0.00765	CcSEcCtD
Tiludronate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00306	0.00763	CcSEcCtD
Tiludronate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00306	0.00763	CcSEcCtD
Tiludronate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00302	0.00754	CcSEcCtD
Tiludronate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.003	0.00747	CcSEcCtD
Tiludronate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00296	0.00738	CcSEcCtD
Tiludronate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00296	0.00738	CcSEcCtD
Tiludronate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00292	0.00728	CcSEcCtD
Tiludronate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00291	0.00724	CcSEcCtD
Tiludronate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.0029	0.00723	CcSEcCtD
Tiludronate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00289	0.00721	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.00289	0.00931	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00282	0.00907	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00282	0.00907	CbGpPWpGaD
Tiludronate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00279	0.00697	CcSEcCtD
Tiludronate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00276	0.00687	CcSEcCtD
Tiludronate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00269	0.0067	CcSEcCtD
Tiludronate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00269	0.0067	CcSEcCtD
Tiludronate—PTPN1—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.00264	0.0085	CbGpPWpGaD
Tiludronate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00263	0.00656	CcSEcCtD
Tiludronate—PTPN1—Immune System—LY96—chronic obstructive pulmonary disease	0.00257	0.00826	CbGpPWpGaD
Tiludronate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00256	0.00639	CcSEcCtD
Tiludronate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00256	0.00639	CcSEcCtD
Tiludronate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00254	0.00632	CcSEcCtD
Tiludronate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00251	0.00625	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.00251	0.00807	CbGpPWpGaD
Tiludronate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00248	0.00617	CcSEcCtD
Tiludronate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00248	0.00617	CcSEcCtD
Tiludronate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00243	0.00604	CcSEcCtD
Tiludronate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00242	0.00603	CcSEcCtD
Tiludronate—Headache—Formoterol—chronic obstructive pulmonary disease	0.00235	0.00585	CcSEcCtD
Tiludronate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00235	0.00585	CcSEcCtD
Tiludronate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00234	0.00583	CcSEcCtD
Tiludronate—Headache—Montelukast—chronic obstructive pulmonary disease	0.0023	0.00573	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.00225	0.00724	CbGpPWpGaD
Tiludronate—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00223	0.00556	CcSEcCtD
Tiludronate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00222	0.00554	CcSEcCtD
Tiludronate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00222	0.00554	CcSEcCtD
Tiludronate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00221	0.00552	CcSEcCtD
Tiludronate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00218	0.00543	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.00213	0.00687	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.00213	0.00686	CbGpPWpGaD
Tiludronate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0021	0.00523	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.00203	0.00653	CbGpPWpGaD
Tiludronate—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00173	0.00432	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00171	0.00549	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00171	0.00549	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—IL6—chronic obstructive pulmonary disease	0.0017	0.00547	CbGpPWpGaD
Tiludronate—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00162	0.00404	CcSEcCtD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00158	0.0051	CbGpPWpGaD
Tiludronate—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00154	0.00383	CcSEcCtD
Tiludronate—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00154	0.00383	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.00147	0.00473	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.00145	0.00466	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL1B—chronic obstructive pulmonary disease	0.00143	0.00462	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.00142	0.00458	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.00135	0.00434	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00134	0.00335	CcSEcCtD
Tiludronate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00134	0.00334	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.00131	0.00421	CbGpPWpGaD
Tiludronate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.0013	0.00323	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.00129	0.00416	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.00129	0.00416	CbGpPWpGaD
Tiludronate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00127	0.00317	CcSEcCtD
Tiludronate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.0012	0.003	CcSEcCtD
Tiludronate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.0012	0.003	CcSEcCtD
Tiludronate—PTPN1—Immune System—TLR2—chronic obstructive pulmonary disease	0.00117	0.00375	CbGpPWpGaD
Tiludronate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00116	0.0029	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.0011	0.00354	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—ALB—chronic obstructive pulmonary disease	0.0011	0.00353	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—KL—chronic obstructive pulmonary disease	0.0011	0.00353	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HDAC2—chronic obstructive pulmonary disease	0.00109	0.0035	CbGpPWpGaD
Tiludronate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00264	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.00105	0.00338	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.00104	0.00336	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.00104	0.00336	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—KL—chronic obstructive pulmonary disease	0.00101	0.00326	CbGpPWpGaD
Tiludronate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00251	CcSEcCtD
Tiludronate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000974	0.00243	CcSEcCtD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.00095	0.00306	CbGpPWpGaD
Tiludronate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000923	0.0023	CcSEcCtD
Tiludronate—PTPN1—Immune System—CD8A—chronic obstructive pulmonary disease	0.000883	0.00284	CbGpPWpGaD
Tiludronate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000875	0.00218	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	0.00084	0.0027	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000822	0.00264	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000762	0.00245	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000762	0.00245	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ERBB3—chronic obstructive pulmonary disease	0.000759	0.00244	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000757	0.00244	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CRP—chronic obstructive pulmonary disease	0.000751	0.00242	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—TLR4—chronic obstructive pulmonary disease	0.00072	0.00232	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000709	0.00228	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000709	0.00228	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000694	0.00224	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000654	0.00211	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000654	0.00211	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NOS2—chronic obstructive pulmonary disease	0.000632	0.00204	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000584	0.00188	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000584	0.00188	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000572	0.00184	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000533	0.00171	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000531	0.00171	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000531	0.00171	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000511	0.00165	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000511	0.00165	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NOS3—chronic obstructive pulmonary disease	0.000508	0.00164	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000475	0.00153	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000475	0.00153	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL1B—chronic obstructive pulmonary disease	0.000469	0.00151	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000373	0.0012	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000373	0.0012	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—EGFR—chronic obstructive pulmonary disease	0.000357	0.00115	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000356	0.00115	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000356	0.00115	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TGFB1—chronic obstructive pulmonary disease	0.000336	0.00108	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—EGFR—chronic obstructive pulmonary disease	0.00033	0.00106	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000316	0.00102	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000316	0.00102	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000286	0.00092	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000286	0.00092	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL6—chronic obstructive pulmonary disease	0.000274	0.000883	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000257	0.000826	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000257	0.000826	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IL6—chronic obstructive pulmonary disease	0.000253	0.000816	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000235	0.000758	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000235	0.000758	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000231	0.000743	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000231	0.000743	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000194	0.000624	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000194	0.000624	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.000177	0.000571	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.000177	0.000571	CbGpPWpGaD
